ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PRTC PureTech Health PLC

23.59
0.00 (0.00%)
Pre Market
Last Updated: 09:29:20
Delayed by 15 minutes
Name Symbol Market Type
PureTech Health PLC NASDAQ:PRTC NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 23.59 22.15 22.67 0 09:29:20

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

24/08/2021 11:56am

Edgar (US Regulatory)




 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of June 2021
Commission File Number 001-39670
 
 
PURETECH HEALTH PLC
 

6 Tide Street, Suite 400
Boston, Massachusetts 02210
Attention: Chief Executive Officer
(617) 482-2333
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                Form 40-F  ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  o





INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Attached to this Report on Form 6-K as Exhibit 99.1 is a copy of the press release of PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) titled "PureTech Health plc – Half-Year Report".
Exhibits
  
PureTech Health plc Press Release, dated August 24, 2021, "PureTech Health plc – Half-Year Report"




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PURETECH HEALTH PLC
Date: August 23, 2021
By: /s/ Daphne Zohar
Name: Daphne Zohar
Title: Chief Executive Officer




1 Year PureTech Health Chart

1 Year PureTech Health Chart

1 Month PureTech Health Chart

1 Month PureTech Health Chart